![](/img/cover-not-exists.png)
Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors
Gregorc, V., De Braud, F. G., De Pas, T. M., Scalamogna, R., Citterio, G., Milani, A., Boselli, S., Catania, C., Donadoni, G., Rossoni, G., Ghio, D., Spitaleri, G., Ammannati, C., Colombi, S., CaligarVolume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-10-1376
Date:
April, 2011
File:
PDF, 259 KB
english, 2011